Cargando…
An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics
In recent years, off-label and unlicensed drug use has extensively developed in the paediatric population. For a long time, clinical trials in the paediatric population were considered complicated to perform because of ethical problems, causing frequent off-label use. Off-label drug use remains an i...
Autores principales: | Bernardini, Roberto, Toschi Vespasiani, Gaia, Giannetti, Arianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144580/ https://www.ncbi.nlm.nih.gov/pubmed/35630042 http://dx.doi.org/10.3390/medicina58050625 |
Ejemplares similares
-
Cow’s Milk Protein Allergy as a Model of Food Allergies
por: Giannetti, Arianna, et al.
Publicado: (2021) -
Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009) -
Development of Monoclonal Antibodies in China: Overview and Prospects
por: Zhang, Mao-Yu, et al.
Publicado: (2015) -
Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists
por: van Hoorn, Camille E., et al.
Publicado: (2020) -
Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)